SCHEMBL1272193

SCHEMBL1272193

COc1ccc(Cl)c(-c2ccc(N)c(N)c2C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 2/20 0.44
▸ HSP90AB1 P08238 2/20 0.44
▸ SCN10A Q9Y5Y9 3/20 0.40
▸ MAPT P10636 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MEN1 O00255 3/20 0.38
▸ KMT2A Q03164 3/20 0.38
▸ THRB P10828 2/20 0.38
▸ CYP3A4 P08684 2/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ BLM P54132 1/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ RAB9A P51151 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ PDE2A O00408 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1272538 0.90 HSP90AA1 (0.45) HSP90AA1HSP90AB1MAPTALDH1A1MEN1
SCHEMBL1272231 0.83 ALDH1A1 (0.40) MAPTALDH1A1MEN1KMT2ATHRB
SCHEMBL1272800 0.78 KDM4E (0.42) MAPTALDH1A1KMT2ACYP3A4KDM4E
SCHEMBL1272136 0.76 TDO2 (0.46) MAPTALDH1A1KMT2ACYP3A4KDM4E
SCHEMBL19785375 0.74 HSP90AA1 (0.56) HSP90AA1HSP90AB1SCN10AMAPTALDH1A1
SCHEMBL15751000 0.71 HSP90AA1 (0.51) HSP90AA1HSP90AB1SCN10AMAPTALDH1A1
SCHEMBL110854 0.71 ALDH1A1 (0.57) HSP90AA1HSP90AB1MAPTALDH1A1MEN1
SCHEMBL3589994 0.71 NOTUM (0.47) ALDH1A1CYP3A4CYP1A2CYP2C9CYP2C19
SCHEMBL1337598 0.71 HSP90AA1 (0.48) HSP90AA1HSP90AB1SCN10AMAPTALDH1A1
SCHEMBL1336743 0.70 HSP90AA1 (0.47) HSP90AA1HSP90AB1SCN10AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110034526-A1 Benzimidazole Compounds WYETH LLC (US) 2011-02-10 — — US disclosed
EP-2231617-A1 BENZIMIDAZOLE COMPOUNDS Wyeth LLC (US) 2010-09-29 — — EP disclosed
WO-2009086138-A1 BENZIMIDAZOLE COMPOUNDS WYETH (US) 2009-07-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110034526-A1 Benzimidazole Compounds NR1H4, NR1H2, NR1H3 HSP90AA1 3666/4885HSP90AB1 2884/4885SCN10A 3150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback